List of poster contributions

A detailed overview of all events can be found in the conference planner.

Filter
Code
Title
P001
P002
Successful Treatment of Refractory Genital Lichen Simplex Chronicus with Dupilumab
Poster 1.1 Inflammatory and immune-mediated dermatoses
M. Blank Presenter Dermacenter AG, Küssnacht a.R.B. Schlagenhauff Dermacenter AG, Küssnacht a.R.
P003
Bimekizumab 3-year efficacy and safety in patients with hidradenitis suppurativa: Results from BE HEARD I&II and EXTENSION
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. Ingram Department of Dermatology & Academic Wound Healing, Division of Infection and Immunity, Cardiff University, Cardiff, UK, and European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany A. Kimball Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USAA. Garg Northwell, New Hyde Park, New York, USAF. Bechara Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, and ICH – International Center for Hidradenitis Suppurativa/Acne Inversa, Ruhr-University Bochum, Bochum, GermanyB. Kirby European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and St Vincent’s University Hospital, Elm Park and the Charles Institute, University College Dublin, Dublin, Republic of IrelandA. Morita Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, JapanW. Gulliver† European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and Newlab Clinical Research Inc., St John's, Newfoundland and Labrador, CanadaB. Lukowski Vedim/UCB, Warsaw, PolandN. Hurni Presenter UCB, Bulle, SwitzerlandC. Sayed European Hidradenitis Suppurativa Foundation (EHSF) e.V., Dessau, Germany, and Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
P004
Severe Persistent Gestational Pemphigoid Beyond Pregnancy: Successful Control with Dupilumab–Omalizumab Combination
Poster 1.1 Inflammatory and immune-mediated dermatoses
T. Moreau Presenter CHUV - Centre hospitalier universitaire vaudoisH. WüthrichM. GillietT. Caplanusi
P005
Beyond classic bullae: Anti-p200 Bullous Pemphigoid Mimicking Erythema gyratum repens with Subsequent Cancer Diagnosis
Poster 1.1 Inflammatory and immune-mediated dermatoses
E. Bulliard Presenter CHUV (Centre Hospitalier Universitaire Vaudois)
P006
Severe confluent and reticulated papillomatosis
Poster 1.1 Inflammatory and immune-mediated dermatoses
B. Signer Presenter Inselspital BernS. Seyed Jafari Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Böll Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
P007
Tralokinumab treatment in patients with atopic dermatitis and moderate-to-severe hand involvement: Results from the 32-week phase 3b ADHAND trial
Poster 1.1 Inflammatory and immune-mediated dermatoses
B. EhstR. WarrenH. HongD. LeeA. MetelitsaS. VolcM. TauberA. TindbergF. Meiler Presenter L. Stein-Gold
P008
Pigmented Rashes: A Diagnostic Challenge in Clinical Dermatology
Poster 1.1 Inflammatory and immune-mediated dermatoses
S. Warraich Presenter Landeskrankenhaus BludenzJ. Obed Broward Dermatology & Cosmetic Specialists
P009
Efficacy of Lebrikizumab in Pediatric Generalized Hypertrophic Lichen Planus
Poster 1.1 Inflammatory and immune-mediated dermatoses
E. Burgener Presenter CHUVS. Sanii
P010
Baseline burden and treatment history of adolescents with moderate to severe Chronic Hand Eczema (CHE) enrolled in the randomized phase 3 DELTA TEEN trial
Poster 1.1 Inflammatory and immune-mediated dermatoses
S. MolinD. RubelF. NavarroZ. ReguiaiS. De SchepperJ. HalpernD. MarcouxJ. SuF. Meiler Presenter LEO Pharmaceutical Products Sarath Ltd.L. Eichenfield
P011
Long-term (≥3 year) efficacy and safety of subcutaneous spesolimab for treatment of generalized pustular psoriasis: Results from the EFFISAYIL program
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. GudjonssonA. Navarini Presenter R. LangleyJ. KruegerA. MostaghimiA. BurdenM. TangJ. ReardonC. ThomaA. Morita
P012
Eosinophilic Annular Erythema Successfully Treated with Omalizumab
Poster 1.1 Inflammatory and immune-mediated dermatoses
E. Janušonytė Presenter Hôpitaux Universitaires de GenèveS. Menzinger Hôpitaux Universitaires de GenèveG. Kaya Hôpitaux Universitaires de GenèveE. Laffitte Hôpitaux Universitaires de Genève
P013
Chronic Relapsing Pruritic Blaschkoid Dermatitis in Adulthood: A Clinicopathologic Pitfall with Extensive Negative Workup
Poster 1.1 Inflammatory and immune-mediated dermatoses
E. Casañas Quintana Presenter Inselspital - Universitätsspital BernN. Mehta Department of Dermatology and Venereology, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaR. Wolf Inselspital - Universitätsspital BernN. Yawalkar Inselspital - Universitätsspital Bern
P014
A case of Palmoplantar Pustular Psoriasis (PPP) effectively treated with the IL 17A/F inhibitor bimekizumab
Poster 1.1 Inflammatory and immune-mediated dermatoses
F. Ney Presenter Dermatology & Skin Care ClinicV. Emelianov Dermatology & Skin Care ClinicA. Schumacher Dermatology & Skin Care ClinicR. Genders Dermatology & Skin Care ClinicA. Valipour Dermatology & Skin Care ClinicA. Jalili Dermatology & Skin Care Clinic
P015
A wheelchair-bound patient: What can dermatology do?
Poster 1.1 Inflammatory and immune-mediated dermatoses
M. Hofer Presenter Kantonsspital AarauL. Krähenbühl Kantonsspital Aarau
P016
Genital Mucocutaneous Manifestations after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Observational Analysis of GVHD and Non-GVHD Lesions
Poster 1.1 Inflammatory and immune-mediated dermatoses
M. Harder Presenter Universitätsspital Basel (USB)S. Müller Universitätsspital Basel (USB)
P017
Dramatic and ultra-rapid response to adalimumab after a single dose in severe nodulocystic acne in a child
Poster 1.1 Inflammatory and immune-mediated dermatoses
C. Giangaspero Presenter Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland.M. Gilliet Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland.S. Sanii Department of Dermatology, Lausanne University Hospital CHUV, Lausanne, Switzerland.
P018
Concomitant Atopic Dermatitis and Psoriasis in a Single Patient: Molecular Evidence for the Coexistence of Two Distinct Diseases
Poster 1.1 Inflammatory and immune-mediated dermatoses
H. Cometto Presenter Lausanne University Hospital Department of Dermatology and VenereologyJ. Di Domizio Lausanne University Hospital Department of Dermatology and VenereologyM. Gilliet Lausanne University Hospital Department of Dermatology and Venereology
P019
Nemolizumab is a novel treatment option in dominant dystrophic epidermolysis bullosa pruriginosa
Poster 1.1 Inflammatory and immune-mediated dermatoses
E. Janušonytė Presenter Division of Dermatology, Geneva University HospitalsA. David Division of Dermatology, Geneva University HospitalsE. Laffitte Division of Dermatology, Geneva University Hospitals
P020
Pityriasis rubra pilaris mimicking psoriasis in a child: when molecular profiling outweighs histopathology
Poster 1.1 Inflammatory and immune-mediated dermatoses
P. Maida Presenter CHUV & University of LausanneS. SaniiM. GillietC. ConradL. Bianchetti
P021
Lebrikizumab Provides Clinically Meaningful Response in Face and Hands in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: ADhope 1 Study
Poster 1.1 Inflammatory and immune-mediated dermatoses
C. Vestergaard Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, DenmarkJ. Seneschal Department of Dermatology, University of Bordeaux, Bordeaux, France; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, FranceS. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, GermanyA. Wollenberg University Medical Center of Augsburg, Augsburg, Germany; Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; Department of Dermatology and Allergology, LMU Hospital, Munich, GermanyA. Irvine Department of Clinical Medicine, Trinity College Dublin, Dublin, IrelandH. Agell Almirall S.A., Barcelona, SpainJ. Bancells Almirall S.A., Barcelona, SpainV. Sapena Almirall S.A., Barcelona, SpainF. Oestereich Presenter Almirall AG, Wallisellen, SwitzerlandD. Thaçi Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany
P022
Comparative Efficacy of Janus Kinase Inhibitors for Scalp Hair, Eyebrow, and Eyelash Regrowth in Adults and Adolescents with Alopecia Areata: A Systematic Literature Review and Network Meta-Analysis
Poster 1.1 Inflammatory and immune-mediated dermatoses
A. MostaghimiA. SolimanS. WangK. WesterhoffJ. WoolleyA. LazarH. TeixeiraM. Iorizzo Presenter T. Passeron
P023
Case report of late-onset Parry-Romberg syndrome in a 58-year-old woman
Poster 1.1 Inflammatory and immune-mediated dermatoses
T. Ragonesi Presenter Luzerner KantonspitalS. Furrer-Matcau Luzern Kantonspital
P024
Efficacy and Safety of Lebrikizumab is Maintained up to 4 Years in Patients with Moderate-to-Severe Atopic Dermatitis: First Year of ADlong Long-Term Extension Trial
Poster 1.1 Inflammatory and immune-mediated dermatoses
S. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, GermanyA. Irvine Department of Clinical Medicine, Trinity College Dublin, Dublin, IrelandD. Thaçi Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, GermanyJ. Szepietowski Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, PolandT. Biedermann Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, GermanyH. Agell Almirall S.A.Y. Mihaylov Almirall S.A., Barcelona, SpainB. Kostov Almirall S.A., Barcelona, SpainR. Coll Almirall S.A., Barcelona, SpainW. Romero Eli Lilly and Company, Indianapolis, IN, USAF. Oestereich Presenter Almirall AGK. Reich Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
P025
Bimekizumab Reduces Draining Tunnel Count Over 3 Years in Hidradenitis Suppurativa: Data from BE HEARD EXTENSION
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. Hsiao Department of Dermatology, University of Southern California, Los Angeles, CA, USAH. Naik Department of Dermatology, University of California, San Francisco, CA, USAA. Kimball Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USAA. Martorell Department of Dermatology, Hospital de Manises, Valencia, Spain, and European Hidradenitis Suppurativa Foundation e.V., Dessau, GermanyP. Becherel European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany, Unité de Dermatologie et Immunologie Clinique, Hôpital Privé d'Antony Université, Paris, France, and Groupe d'Etudes Multicentriques Reso, Saint-Maur-des-Fossés, FranceM. Gooderham SKiN Centre for Dermatology, Probity Medical Research, Peterborough, ON, Canada, and Queen’s University, Kingston, ON, CanadaT. Maekawa Department of Dermatology, Jichi Medical University, Saitama Medical Center, Saitama, JapanB. Lukowski Vedim/UCB, Warsaw, PolandN. Hurni Presenter UCB, Bulle, SwitzerlandF. Bechara Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany, and ICH – International Center for Hidradenitis Suppurativa / Acne Inversa, Ruhr-University Bochum, Germany
P026
Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. Merola Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USAA. Armstrong University of California Los Angeles (UCLA), Los Angeles, CA, USAD. Balak Department of Dermatology, Leiden University Medical Center, Leiden, The NetherlandsJ. Hawkes Oregon Medical Research Center, Portland, OR, USAL. Kircik Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USAF. Lovegrove Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, CanadaT. Jeffray UCB, Oakville, ON, CanadaS. Kavanagh UCB, Morrisville, NC, USAN. Hurni Presenter UCB, Bulle, SwitzerlandR. Langley Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada
P027
Clinical presentation and treatment outcomes in Melkersson–Rosenthal syndrome and cheilitis granulomatosa: A retrospective cohort study
Poster 1.1 Inflammatory and immune-mediated dermatoses
A. Novakovic Presenter Kantonsspital AarauR. DummerL. KrähenbühlC. Zahn
P028
Drug-induced Grover-like dermatosis beyond targeted therapy: expanding the spectrum of drug-induced acantholytic dermatoses
Poster 1.1 Inflammatory and immune-mediated dermatoses
P. Maida Presenter CHUV & University of LausanneJ. DuboisM. GillietM. VernezC. Biatta
P029
Once-daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
Poster 1.1 Inflammatory and immune-mediated dermatoses
M. Gooderham SKiNCentre for Dermatology, Queen’s University and Probity Medical Research, Peterborough, Ontario, CanadaV. Laquer First OC Dermatology Research, Fountain Valley, CA, USAJ. Zhang Department of Dermatology, Peking University People's Hospital, Beijing, ChinaJ. Narbutt Department of Dermatology, Paediatric Dermatology and Oncology, Medical University of Lodz, Lodz, PolandA. Morita Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, JapanP. Luna Hospital Alemán de Buenos Aires, Buenos Aires, ArgentinaW. Zhang Takeda Development Center Americas, Inc., Cambridge, MA, USAW. Winkelman Takeda Development Center Americas, Inc., Cambridge, MA, USAE. Angellotti Takeda Development Center Americas, Inc., Cambridge, MA, USAM. Brunori Presenter
P030
Resident macrophage–derived C1q restrains DNA sensing and shapes treatment response in psoriasis.
Poster 1.1 Inflammatory and immune-mediated dermatoses
F. Saidoune Presenter CHUVN. LoftH. ComettoJ. Di DomizioC. ConradL. SkovM. Gilliet
P031
Selective costimulation blocker belatacept induces psoriasis in renal transplant recipients.
Poster 1.1 Inflammatory and immune-mediated dermatoses
G. Blanchard Presenter HUG - Hôpitaux Universitaires de GenèveS. Menzinger HUG - Hôpitaux Universitaires de GenèveG. Kaya HUG - Hôpitaux Universitaires de GenèveK. Hadaya Clinique des Grangettes, Hirslanden, Geneva, Switzerland E. Laffitte HUG - Hôpitaux Universitaires de Genève
P032
Gene expression profiles of granulomatous skin disease using the Nanostring technology
Poster 1.1 Inflammatory and immune-mediated dermatoses
G. Knechtl Presenter Inselspital Bern - DermatologieA. Junge Inselspital Bern - DermatologieJ. Di Domizio CHUV & University of LausanneS. Cazzaniga Centro Studi GISED, Bergamo, ItalyM. Gilliet CHUV & University of LausanneC. Schlapbach Inselspital Bern - Dermatologie
P033
P034
A cytotoxic plasmacytoid dendritic cell subset contributes to interface dermatitis in lichen planus
Poster 1.1 Inflammatory and immune-mediated dermatoses
N. LesjakM. SoubeyrandM. GillietJ. Di Domizio Presenter Lausanne University Hospital (CHUV)
P035
Prurigo Pigmentosa Associated with Metabolic Abnormalities, Nutritional Supplementation, and Psychological Stress in a Young Woman: A Case Report
Poster 1.1 Inflammatory and immune-mediated dermatoses
A. Stiube Presenter Dermacenter AG, Küssnacht am RigiB. Schlagenhauff Dermacenter AG, Küssnacht am RigiV. Tenyi Dermacenter AG, Küssnacht am Rigi
P036
Urticarial annular eruption revealing Capnocytophaga canimorsus bacteraemia after a dog bite
Poster 1.1 Inflammatory and immune-mediated dermatoses
A. Pagani Presenter HUG - Hôpitaux Universitaires de GenèveM. Sabau HUG - Hôpitaux Universitaires de GenèveR. Merat HUG - Hôpitaux Universitaires de GenèveS. Menzinger HUG - Hôpitaux Universitaires de GenèveG. Kaya HUG - Hôpitaux Universitaires de GenèveD. Pastor HUG - Hôpitaux Universitaires de GenèveG. Russo HUG - Hôpitaux Universitaires de Genève
P037
Adult-onset of linear IgA dermatosis: A rare presentation in a 76-year-old male
Poster 1.1 Inflammatory and immune-mediated dermatoses
R. Rodoquino Presenter Ente Ospedaliero Cantonale (EOC), BellinzonaM. MadanchiH. BeltraminelliR. Curatolo
P038
Cutaneous Sarcoidosis: When Skin Findings Lead to the Diagnosis of Systemic Disease – A Case Series
Poster 1.1 Inflammatory and immune-mediated dermatoses
C. Schütz Presenter Dermacenter AGB. Schlagenhauff Dermacenter AG
P039
Rapid clustering of Dermatomyositis: A three-month case series of four patients
Poster 1.1 Inflammatory and immune-mediated dermatoses
R. Rodoquino Presenter Ente Ospedaliero Cantonale (EOC), BellinzonaR. CuratoloG. CaroL. CortiL. BruschiM. HilbersM. MadanchiC. MangasH. Beltraminelli
P040
Risankizumab Treatment Is Associated With Lower Risk of Developing Psoriatic Arthritis in Patients With Psoriasis Compared to Other Targeted Immunomodulators (Encore publication of an original abstract)
Poster 1.1 Inflammatory and immune-mediated dermatoses
B. StroberE. SongC. BunickR. TaG. St JohnV. StakiasC. LiD. SharmaA. ArmstrongT. Kündig Presenter J. Merola
P041
A Human 3D Epidermal Model of Acute Cutaneous GVHD
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. Fröhlich Presenter Department of Biomedicine, University Hospital and University of BaselT. Dittmar Department of Biomedicine, University Hospital and University of BaselE. Parente Department of Biomedicine, University Hospital and University of BaselA. Chancellor Department of Biomedicine, University Hospital and University of BaselE. Contassot Department of Biomedicine, University Hospital and University of BaselA. Navarini Department of Biomedicine, University Hospital and University of Basel
P042
Molecular dissection of granulomatous skin diseases – granuloma annulare versus sarcoidosis
Poster 1.1 Inflammatory and immune-mediated dermatoses
L. Cotting Presenter CHUV (Centre Hospitalier Universitaire Vaudois)J. Di DomizioK. Kedra University of RzeszówA. Reich University of RzeszówC. Schlapbach Insel Spital BernM. Gilliet CHUV (Centre Hospitalier Universitaire Vaudois)C. Conrad CHUV (Centre Hospitalier Universitaire Vaudois)
P043
An Unexpected Site: Challenging Diagnosis and Therapy of Necrobiosis Lipoidica on the Elbow
Poster 1.1 Inflammatory and immune-mediated dermatoses
C. Vogel Presenter Inselspital Bern, Bern, Switzerland A. Rabufetti Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandL. Feldmeyer Luzerner Kantonsspital, Luzern, SwitzerlandR. Blum Medics Pathologie Bern, SwitzerlandL. Borradori Inselspital Bern, Bern, Switzerland
P044
Severe, Therapy-Resistant Generalized Lichen Sclerosus with Morphea Overlap Successfully Treated with Intravenous Immunoglobulin and Type 1 Interferon Receptor Monoclonal Antibody Infusion: A Case Report
Poster 1.1 Inflammatory and immune-mediated dermatoses
J. Hafner Presenter Dermatologische Klinik, Universitätsspital ZürichA. Alhowaish Dermatologische Klinik, Universitätsspital ZürichD. Mayer Dermatologische Klinik, Universitätsspital ZürichU. GerthJ. Kamarachev Dermatologische Klinik, Universitätsspital ZürichF. Alotaibi Dermatologische Klinik, Universitätsspital ZürichA. KoliosM. Hofer Dermatologische Klinik, Universitätsspital Zürich
P045
Topical Ruxolitinib for Immune Checkpoint Inhibitor–Induced Bullous Pemphigoid: A Case Report
Poster 1.1 Inflammatory and immune-mediated dermatoses
I. Lederbogen Presenter University Hospital ZurichB. Meier-Schiesser University Hospital Zurich
P046
Real-world Management of Bullous Pemphigoid in Switzerland: A Cross-Sectional Survey of Dermatologists
Poster 1.1 Inflammatory and immune-mediated dermatoses
L. Borradori Presenter Inselspital, Universitätsspital BernL. Steffan Ipsos GmbH, GermanyC. Hartmann Ipsos GmbH, GermanyM. Kobelt Ipsos GmbH, GermanyS. Pfister Sanofi-Aventis (Schweiz) AGM. Perny Sanofi-Aventis (Schweiz) AG
P047
Increased Burden of Hypertension and Diabetes in Swiss Psoriasis Patients: A Registry-Based Comparison with the General Population
Poster 1.1 Inflammatory and immune-mediated dermatoses
I. Pramono USZT. Steybe Universitätsspital BaselP. Simmler Presenter AbbVie AGR. LooserV. Djamei Swiss4ward, ZurichL. Maul University Hospital Zurich, Zurich, SwitzerlandT. Kündig University Hospital ZurichK. Heidemeyer Bern University HopsitalN. Yawalkar Inselspital BernC. Conrad CHUV (Centre Hospitalier Universitaire Vaudois)W. Boehncke Hòpitaux Universitaires de GenèveA. Navarini Universitätsspital Basel (USB)J. Maul Universitätsspital Zürich USZ
P048
Unusual Perforating Necrobiotic Granulomatous Reaction Secondary to Red Tattoo Ink
Poster 1.1 Inflammatory and immune-mediated dermatoses
C. Anderlini Presenter Hospital Privado Universitario de CórdobaS. Zanitti Hospital Privado Universitario de CórdobaE. Bravo Hospital Privado Universitario de CórdobaM. Mazzota Hospital Privado Universitario de CórdobaE. Valente Hospital Privado Universitario de Córdoba
P049
Low-dose systemic acitretin clears therapy-resistant periungual verrucae: a synergistic combined approach
Poster 1.2 Infectious Diseases (including STD-STI)
F. Brand Presenter Insel Gruppe AG BernM. Gottschalk Insel Gruppe AG Bern
P050
Rapid point-of-care testing for genital chlamydia and gonorrhea infections: a promising new tool
Poster 1.2 Infectious Diseases (including STD-STI)
A. Pagani Presenter Hôpitaux universitaires de Genève (HUG)N. Chartier Testmate Health SAL. Costa Testmate Health SAL. Dumont Testmate Health SAS. Sahi Testmate Health SAJ. Schrenzel Hôpitaux universitaires de Genève (HUG)L. Toutous Trellu Hôpitaux universitaires de Genève (HUG)
P051
Klebsiella aerogenes as a Cause of Recurrent Beard Folliculitis
Poster 1.2 Infectious Diseases (including STD-STI)
M. Sabau Presenter HUG - Hôpitaux Universitaires de GenèveM. BlanchardF. BertoneL. Toutous Trellu
P052
Autochthonous leishmaniasis in Europe
Poster 1.2 Infectious Diseases (including STD-STI)
B. Signer Presenter Inselspital BernL. Borradori Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandR. Wolf Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Junge Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
P053
A red, swollen hand: consider acrodermatitis chronica atrophicans as well!
Poster 1.2 Infectious Diseases (including STD-STI)
C. Mainetti Presenter Private Practice, Bellinzona, SwitzerlandH. Beltraminelli Department of Dermatology, Department of Pathology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
P054
Clinical presentation of Leprosy: clinical cases from Sri Lanka
Poster 1.2 Infectious Diseases (including STD-STI)
F. Ney Presenter Dermatology & Skin Care ClinicA. Vanegas Ramirez Department of Dermatology and Venereology University Hospital Cologne A. Jalili Dermatology & Skin Care Clinic
P055
New insights into neurosyphilis by digitizing manuscript medical records
Poster 1.2 Infectious Diseases (including STD-STI)
M. Lamrayah Presenter Faculty of Medicine, University of Geneva, SwitzerlandS. Gabay Faculty of Letters, University of Geneva, SwitzerlandJ. Falciola Hopitaux Universitaire de Genève HUG/UniGeL. Toutous Trellu Hopitaux Universitaire de Genève HUG/UniGe
P056
The many faces of neurosyphilis: a clinicopathological re-evaluation of historical cases
Poster 1.2 Infectious Diseases (including STD-STI)
V. Alber Presenter Hôpitaux Universitaire de Genève (HUG)M. Lamrayah UNIGEJ. Falciola HUG - Geneva University Hospitals/ UNIGEL. Toutous Trellu Hopitaux Universitaire de Genève HUG/UniGe
P057
Spotted Fever Group Rickettsiosis Following Rural Exposure in Germany: A Case Report
Poster 1.2 Infectious Diseases (including STD-STI)
A. Steiger Presenter L. Markovic Presenter Universitätsspital Basel
P058
Virtual Reality in Psychodermatology: A Novel Dimension of Treatment
Poster 2.1 Psychodermatology
R. Velikova Presenter University Hospital Basel, Department of Dermatology, Basel, SwitzerlandC. Abel-Green University Hospital Basel, Department of Dermatology, Basel, SwitzerlandS. Müller University Hospital Basel, Department of Dermatology, Basel, Switzerland
P059
High Awareness but Limited Assessment of Psychological and Sexual Health in Dermatology Practice: A Survey of Swiss Dermatologists
Poster 2.1 Psychodermatology
K. Kedra Presenter University of RzeszowS. Cazzaniga Bern University Hospital, Bern, SwitzerlandH. Beltraminelli Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.N. Yawalkar Bern University Hospital, Bern, SwitzerlandK. Heidemeyer Bern University Hospital, Bern, SwitzerlandA. Reich University of RzeszowA. Rabufetti Bern University Hospital, Bern, Switzerland
P060
Scents for Relief: Rationale and Odour Selection for Aromatherapy in Chronic Pruritus
Poster 2.1 Psychodermatology
H. Aviv Presenter USB BaselR. von Rohr UPK BaselS. Broggi Sela Centre for Integral Health and Aromatherapy KönizC. Andrist USB BaselA. Derleth USB BaselS. Müller USB Basel
P061
Pigmented trichoblastoma arising in nevus sebaceus in a patient with prior scalp melanoma: a diagnostic challenge
Poster 2.2 Dermato-Oncology
D. Amozova Presenter HOCH Health Ostschweiz Kantonsspital St. GallenN. Denisjuk HOCH Health Ostschweiz Kantonsspital St. GallenR. Mendez Lopez HOCH Health Ostschweiz Kantonsspital St. Gallen
P062
P063
P064
P065
Low Number-Needed-to-Biopsy Enables Early Detection of Subsequent Melanomas in a Swiss High-Risk Cohort
Poster 2.2 Dermato-Oncology
S. Wespi Presenter University Hospital Zurich (USZ)N. Lerjen University Hospital Zurich (USZ)J. Ziegler University Hospital Zurich (USZ)T. Kündig University Hospital Zurich (USZ)J. Mangana University Hospital Zurich (USZ), Skin Cancer Unit, Comprehensive Cancer Centre, University Hospital Zurich, ZurichL. Maul University Hospital Zurich (USZ)
P066
Retrospective real-world analysis of novel systemic treatment strategies for advanced, resectable skin cancer.
Poster 2.2 Dermato-Oncology
A. Bouri Presenter Kantonsspital Aarau AGA. Bouri Kantonsspital AarauR. DummerL. Kraenhenbuehl
P067
Verrucous squamous cell carcinoma mimicking candida-associated angular cheilitis
Poster 2.2 Dermato-Oncology
S. Marfurt Presenter Cantonal Hospital H-OCH St. Gallen, SwitzerlandN. Zhovta Cantonal Hospital H-OCH St. Gallen, SwitzerlandR. Mendez Lopez Cantonal Hospital H-OCH St. Gallen, Switzerland
P068
Comparative tumor microenvironment profiling in immunocompetent versus immunosuppressed patients with cutaneous squamous cell carcinoma
Poster 2.2 Dermato-Oncology
R. Galalae Presenter G. RestivoM. KatoE. BeebeL. FeldmeyerM. LevesqueR. DummerR. Stäger
P069
Comparison of Accuracy of PET-CT, Ultrasound, and Sentinel Lymph Node Biopsy in the Initial staging Workup of Melanoma: A Multicenter Retrospective Study
Poster 2.2 Dermato-Oncology
D. Turčinas Presenter A. BalllariniJ. ManganaE. RamelytėR. DummerL. Krähenbühl
P070
WNT-Activated Deep Penetrating Nevus Mimicking Acral Melanoma on the Toe: A Case Report with Molecular Characterization
Poster 2.2 Dermato-Oncology
E. Casañas Quintana Presenter Inselspital - Universitätsspital BernF. Dimitriou Inselspital - Universitätsspital BernM. Gottschalk Inselspital - Universitätsspital BernM. Benzaquen Inselspital - Universitätsspital BernH. Dawson Inselspital - Universitätsspital BernR. Wolf Inselspital - Universitätsspital Bern
P071
Avapritinib Achieves Durable Improvement in Skin Findings With a Well-Tolerated Safety Profile in Patients With Indolent Systemic Mastocytosis: Long-term Analyses From the PIONEER Study
Poster 2.2 Dermato-Oncology
K. Hartmann Presenter University Hospital Basel and University of BaselC. Akin Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of MichiganF. Siebenhaar Institute of Allergology, Charité-Universitat Berlin and Humboldt-Universitat zu BerlinS. Broesby-Olsen Department of Dermatology and Allergy Centre, Odense University HospitalH. Oude Elberink Department of Allergology, Groningen Research Institute Asthma and COPD, University Medical Center, University of GroningenT. George Huntsman Cancer Institute and ARUP Laboratories, Department of Pathology, University of Utah School of MedicineH. Lin Blueprint Medicines CorporationI. Bidollari Blueprint Medicines CorporationA. Doyle Blueprint Medicines CorporationL. Madigan Department of Dermatology, University of Utah
P072
Basal Cell Carcinoma in Nevus Sebaceus: Does It Predict Further Malignant Change?
Poster 2.2 Dermato-Oncology
P. Golling Presenter Hautpraxis Dr.SchillerA. Juillerat Hautpraxis Dr.SchillerP. Schiller Hautpraxis Dr.Schiller
P073
Spontaneous remission of relapsed primary cutaneous diffuse large B-cell lymphoma, leg type, with a dual clonal infiltrate
Poster 2.2 Dermato-Oncology
E. Janušonytė Presenter Division of Dermatology, Geneva University HospitalsS. Menzinger Division of Dermatology, Geneva University HospitalsG. Kaya Division of Dermatology, Geneva University HospitalsB. Cortes Division of Dermatology, Geneva University Hospitals
P074
Interpreting Baseline Serum Tryptase During Screening for Clonal Mast Cell Disease in the Presence or Absence of Hereditary Alpha-Tryptasemia
Poster 2.2 Dermato-Oncology
V. Sabato University of Antwerp and Antwerp University HospitalM. Giannetti Division of Allergy and Clinical Immunology, Brigham and Women’s HospitalC. Akin Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of MichiganJ. Jurcic Herbert Irving Cancer Center, and New York-Presbyterian HospitalM. Jara-Acevedo Spanish Network on Mastocytosis and Biomedical Research Institute of Salamanca, University of Salamanca and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400)B. Poladura Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle HospitalR. Sandoval-Arroyo Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle HospitalA. Orfao Spanish Network on Mastocytosis (REMA) and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400) and Biomedical Research Institute of Salamanca, University of SalamancaK. Hartmann Presenter Division of Allergy, Department of Dermatology; Department of Clinical Research; and Department of Biomedicine, University Hospital Basel, and University of BaselI. Álvarez-Twose Spanish Network on Mastocytosis (REMA) and Centro de Investigación Biomédica en Red Cáncer (CIBERONC; CB16/12/00400) and Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Virgen del Valle Hospital
P075
Real-World Efficacy and Safety of Nivolumab plus Relatlimab in Metastasized Melanoma: A Retrospective Single-Center Study
Poster 2.2 Dermato-Oncology
G. Clerici Presenter M. MerdauslM. WeltiJ. ManganaR. DummerE. Ramelyte
P076
Relapse of a pigmented trichoblastoma with basal cell carcinoma arising in a nevus sebaceous
Poster 2.2 Dermato-Oncology
C. Mainetti Presenter Studio Medico Dermatologia, Bellinzona, SwitzerlandH. Beltraminelli Department of Dermatology, Department of Pathology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
P077
Ten years retrospective analysis of clinical characteristics Vitiligo-like depigmentation in treated melanoma patients
Poster 2.2 Dermato-Oncology
G. Caro Presenter Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandM. Rogan Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, SwitzerlandA. Nepote Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandM. Hilbers Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, SwitzerlandG. Burghgraeve Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, SwitzerlandC. Mangas Department of Dermatology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
P078
Blastic Plasmacytoid Dendritic Cell Neoplasm Presenting as Cutaneous Plaque: A Case Report
Poster 2.2 Dermato-Oncology
S. Aycicek Presenter Kühne Dermatology PracticeJ. Galambos Kempf and Pfaltz Histological DiagnosticsW. Kempf Kempf and Pfaltz Histological DiagnosticsA. Kühne Kühne Dermatology Practice
P079
Tumor protease–activated IL-2 variants for conditional immune stimulation
Poster 2.2 Dermato-Oncology
A. NübelingL. FlatzA. CozzioL. Villiger Presenter KSSG
P081
A Multilayer Nanofat Approach to Full-Face Rejuvenation: A Retrospective Case Series
Poster 2.3 Corrective dermatology, dermatocosmetics, lasers
G. Dragieva Presenter Dr. Dragieva AestheticsT. Archimandritis Dr. Dragieva Aesthetics
P082
P083
Analgosedation protocol for pediatric laser and interventional dermatology: a strategy to minimize general anesthesia exposure
Poster 2.3 Corrective dermatology, dermatocosmetics, lasers
M. Blanchard Presenter HUG GenèveJ. Puenchera HUG GenèveH. Laubach HUG GenèveD. Alvarez Martinez HUG Genève
P084
KTP Laser and Lymphatic Drainage in Severe Rosacea with Facial Lymphedema: A Case Report Highlighting a Dual “Gamechanger” Strategy
Poster 2.3 Corrective dermatology, dermatocosmetics, lasers
J. Hafner Presenter Universitätsspital Zürich USZF. Alotaibi Dermatologische Klinik, Universitätsspital ZürichD. Mayer Dermatologische Klinik, Universitätsspital ZürichN. Anasiewicz Dermatologische Klinik, Universitätsspital ZürichA. Alhowaish Dermatologische Klinik, Universitätsspital Zürich
P086
Managing Severe Amivantamab-Associated Scalp Crusting in First-Line EGFR-Mutated NSCLC
Poster 2.4 Therapy, diagnostic tools, and devices
H. Lindemann Presenter L. Krähenbühl
P087
TrophiPatchTM, an Allogenic Stromal Cell Patch for Refractory Chronic Leg Ulcers: Preliminary Clinical Results from a Phase I/IIa Trial in chronic venous leg ulcers
Poster 2.4 Therapy, diagnostic tools, and devices
C. Poletti Presenter D. Pastor Presenter M. LocatelliJ. VillardO. Preynat-SeauveN. BrembillaW. Boehncke
P088
Nemolizumab in prurigo nodularis: efficacy and tolerability in a real-world population
Poster 2.4 Therapy, diagnostic tools, and devices
E. Janušonytė Presenter Division of Dermatology, Geneva University HospitalsE. Laffitte Division of Dermatology, Geneva University Hospitals
P089
Text-only input for artificial intelligence-assisted diagnosis: A real-world teledermatology study from Switzerland
Poster 2.4 Therapy, diagnostic tools, and devices
N. May MüllerE. GoessingerP. GottfroisA. NavariniC. Greis Presenter Universitätsspital Zürich, Dermatologische Klinik
P090
Purple Rain Under Wood’s Light: Illuminating Diagnostic Clues in Dermatology
Poster 2.4 Therapy, diagnostic tools, and devices
R. Curatolo Presenter EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliH. Beltraminelli EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliM. Madanchi EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e Valli
P091
Offline Dermoscopic Screening: Small Specialized Model Outperforms Larger General-Purpose AI Models
Poster 2.4 Therapy, diagnostic tools, and devices
S. Blüthgen Presenter Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandC. Greis Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
P092
Grid patch treatment for localized pruritus: A case series
Poster 2.4 Therapy, diagnostic tools, and devices
C. Andrist University Hospital BaselH. Aviv Presenter University Hospital BaselA. Derleth University Hospital BaselL. Markovic University Hospital BaselA. Navarini University Hospital BaselS. Müller University Hospital Basel
P093
Real-world evaluation of the artificial intelligence-powered WHO Skin NTDs App in Côte d’Ivoire: performance, usability and acceptability study
Poster 2.4 Therapy, diagnostic tools, and devices
C. Hoyer Presenter Hôpitaux Universitaire de Genève (HUG)D. CabuttoA. Fuster-CasanovasJ. Ruiz PostigoL. Toutous TrelluC. Carrion
P094
Lebrikizumab for Paediatric Patients Aged ≥6 Months with Moderate-to-Severe AD: Phase 3 ADorable-1 Week-16 Results
Poster 3.1 Dermato-Paediatrics
L. Eichenfield Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, United StatesJ. Ornelas Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, United StatesV. Prajapati Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CanadaC. Yang Chang Gung University College of Medicine, Taoyuan, TaiwanA. Tanaka Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanS. Weidinger Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Ratzeburger Allee 160, 23538 Lübeck, GermanyC. Flohr Department of Dermatology and Population Health Sciences, King’s College London, London, United KingdomE. Swanson Ada West Dermatology, St Luke's Children's Hospital, ID 83642, Idaho, United StatesL. Martin School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AustraliaF. Oestereich Presenter Almirall AGA. Paller Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States
P095
Molecular Insights into Generalized Lichen Nitidus: Gene Expression Profiling Supports a Lichen Planus–Like Signature
Poster 3.1 Dermato-Paediatrics
M. Gottschalk Presenter C. SchlapbachL. Vuille-GueissazR. WolfO. SteckN. BertschiA. Reimer-Taschenbrecker
P096
Spontaneous resolution of congenital melanocytic naevi on the scalp
Poster 3.1 Dermato-Paediatrics
N. Knöpfel Presenter University Children's Hospital Zurich; Kantonsspital AarauI. Luchsinger University Children's Hospital ZurichJ. Lanz University Children's Hospital Zurich; HOCH Kantonsspital St. GallenA. Schwieger-Briel University Children's Hospital ZurichM. Theiler Pang University Children's Hospital ZurichL. Weibel University Children's Hospital Zurich
P097
New-onset localized hyperhidrosis reveals a dynamic phenotype in involuting infantile hemangiomas
Poster 3.1 Dermato-Paediatrics
J. Lanz University Children's Hospital Zurich; HOCH Kantonnspital St GallenL. Weibel University Children`s Hospital ZurichM. Theiler Pang University Children's Hospital ZurichA. Schwieger-Briel University Children's Hospital ZurichI. Luchsinger University Children's Hospital ZurichH. Khov University Hospital Zurich (USZ)I. Colmenero University Children's Hospital Niño Jesus, MadridA. Cozzio HOCH - Kantonsspital St.GallenN. Knöpfel Presenter University Children's Hospital Zurich; Kantonsspital Aarau
P098
Pediatric extragenital lichen sclerosus: a diagnostic clue to occult genital disease
Poster 3.1 Dermato-Paediatrics
L. Bruschi Presenter EOC (Ente Ospadaliero Cantonale) - Ospedale Regionale di LuganoB. Cattrini EOC (Ente Ospedaliero Cantonale) - Ospedale Regionale di Bellinzona e ValliS. Leoni Parvex Cantonal Institute of Pathology, Ente Ospedaliero Cantonale, Locarno, SwitzerlandI. Terrani EOC (Ente Ospadaliero Cantonale) - Ospedale Regionale di Lugano
P099
Adams-Oliver Syndrome Starts with the Skin: Three Cases Highlighting Early Dermatologic Clues
Poster 3.1 Dermato-Paediatrics
L. Pawlik Presenter L. WeibelM. Theiler PangA. Schwieger-BrielJ. LanzN. KnöpfelI. Luchsinger
P100
Brentuximab vedotin-induced pustular eruption in transformed mycosis fungoides: a diagnostic challenge
Poster 3.2 Dermato-Allergology
E. Janušonytė Presenter Hôpitaux Universitaires de GenèveO. Marchal Hôpitaux Universitaires de GenèveS. Menzinger Hôpitaux Universitaires de GenèveG. Kaya Hôpitaux Universitaires de GenèveB. Cortes Hôpitaux Universitaires de Genève
P101
Contact dermatitis: case report of an unusual manifestation in the context of an allergy to methylisothiazolinone
Poster 3.2 Dermato-Allergology
S. Rey Presenter Luzerner Kantonsspital (LUKS)O. Fuchs Luzerner KantonspitalF. Brand Inselspital Bern
P102
Overlap of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) and haemophagocytic lymphohistiocytosis (HLH): A case report
Poster 3.2 Dermato-Allergology
S. Grimme Presenter Z. Manjaly ThomasM. DickenmannC. MesserliR. DummerL. KrähenbühlE. Steveling-Klein
P103
Real-World Characteristics of Atopic Dermatitis Patients Treated with Nemolizumab: Data from the TREATswitzerland Registry*
Poster 3.2 Dermato-Allergology
E. Janušonytė Presenter Division of Dermatology, Geneva University HospitalsT. Caplanusi Department of Dermatology and Venereology, University Hospital of Lausanne, Lausanne, SwitzerlandK. Hartmann Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, SwitzerlandW. Boehncke Division of Dermatology, Geneva University HospitalsS. Radonjic-Hoesli Department of Dermatology, Inselspital, Bern University Hospital, University of BernK. Thormann Department of Dermatology, Inselspital, Bern University Hospital, University of BernD. Simon Department of Dermatology, Inselspital, Bern University Hospital, University of Berns. TREATswitzerland
P104
Immune Profiling of Bulevirtide Injection-Site Reactions Reveals a Continuum Between Allergic Contact Dermatitis and Drug Hypersensitivity Transcriptomic Profiles
Poster 3.2 Dermato-Allergology
H. Wüthrich Presenter P. BernardJ. Di DomizioA. GirardinM. GillietT. Caplanusi
P105
4-Hexylresorcinol in a Tinted Sunscreen: an Emerging Cosmetic Allergen
Poster 3.2 Dermato-Allergology
E. Janušonytė Presenter Division of Dermatology, Geneva University HospitalsD. Allali Division of Allergy and Immunology, Hôpital de La TourP. PilettaY. Götti-Alipour
P106
Familial Hereditary Alpha Tryptasemia with 15 TPSAB1 Copies: Clinical Variability and Proteomic Insights
Poster 3.2 Dermato-Allergology
V. Baghin Presenter USZ DermatologieM. Misiune Presenter C. LangA. WhiteJ. Trück
P107
Photopatch testing at the Geneva Photobiology Center: A monocentric 10-year retrospective study.
Poster 3.2 Dermato-Allergology
G. Blanchard Presenter HUG - Hôpitaux Universitaires de GenèveP. Piletta-Zanin HUG - Hôpitaux Universitaires de GenèveD. Alvarez Martinez HUG - Hôpitaux Universitaires de Genève
P108
Finger allergic contact dermatitis induced by feline thiamazole cream.
Poster 3.2 Dermato-Allergology
G. Blanchard Presenter HUG - Hôpitaux Universitaires de GenèveO. Marchal HUG - Hôpitaux Universitaires de GenèveO. Sorg UNIGEE. Laffitte HUG - Hôpitaux Universitaires de GenèveP. Piletta-Zanin HUG - Hôpitaux Universitaires de Genève
P109
Distinct Proteomic Signatures in Systemic Mastocytosis are linked to innate activation, ineffective adaptive immune response and neuroimmune remodelling
Poster 3.2 Dermato-Allergology
A. White Presenter Universiity Hospital ZürichM. Ameri University of ZurichM. Bissig University Hospital of Zurich,S. Balabanov University Hospital of Zurich,C. Lang University Hospital Zurich,
P110
A Shared Effector Memory T-Cell Transcriptional Core in Patch Test Reactions to Different Allergens
Poster 3.2 Dermato-Allergology
C. Teofila Presenter CHUV & Université de LausanneJ. Di DomizioA. GirardinM. Gilliet
P111
Management of a severe DRESS with simultaneous multiple drug hypersensitivity
Poster 3.2 Dermato-Allergology
L. Markovic Presenter Universitätsspital BaselA. RomswinkelC. BergerS. Chantraine
P112
New insights in eczema of the elderly: clinical characterization and skin mRNA profiling
Poster 3.2 Dermato-Allergology
K. Kotsia Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandE. Contassot Department of Biomedcine, University Hospital Basel and University of Basel, Basel, SwitzerlandS. Cazzaniga Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandK. Hartmann Department of Clinical Research, University Hospital Basel and University of Basel, Basel, SwitzerlandD. Simon Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Radonjic-Hoesli Presenter Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
P113
The chromatin guardian ATRX is a strong prognostic biomarker in melanoma
Poster 3.3 Dermato-Pathology
C. Frei Presenter University Hospital of ZurichC. Litchfield University Hospital of ZurichA. Mihic Bavarian State Office for Health and Food SafetyF. Prutek University Hospital of ZurichA. Fitsche University Hospital of ZurichF. Wiesmann University Hospital of ZurichM. Wanner Cancer Registry Zurich, Zug, Schaffhausen and SchwyzB. Sobottka University Hospital of ZurichD. Mihic-Probst University Hospital of Zurich
P114
Comparative Clinical and Histological Analysis of Bullous Pemphigoid: Immunotherapy-Associated vs. Spontaneous Onset Cases
Poster 3.3 Dermato-Pathology
T. Gwerder Presenter L. Krähenbühl Kantonsspital Aarau AGJ. Kamarachev USZ DermatologieR. Dummer Kantonspital Aarau AGT. Kündig USZ Dermatologie
P115
Beyond histiocytosis: xanthogranulomatous skin lesions revealing three distinct clonal diseases
Poster 3.3 Dermato-Pathology
N. Staub Presenter Inselspital - Universitätsspital BernT. Hempel Inselspital - Universitätsspital BernM. Gottschalk Inselspital - Universitätsspital BernL. Vuille-Gueissaz Inselspital - Universitätsspital BernR. Wolf Inselspital - Universitätsspital BernL. Borradori Inselspital - Universitätsspital BernC. Schlapbach Inselspital - Universitätsspital BernF. Dimitriou Inselspital - Universitätsspital Bern
P116
Eccrine Syringofibroadenoma Mimicking Necrobiosis Lipoidica: A Case Report
Poster 3.3 Dermato-Pathology
L. Rei Presenter CHUV (Centre Hospitalier Universitaire Vaudois)P. Bernard CHUV (Centre Hospitalier Universitaire Vaudois)O. Gaide CHUV (Centre Hospitalier Universitaire Vaudois)C. Biatta CHUV (Centre Hospitalier Universitaire Vaudois)
P117
A novel, sustainable and cost-effective 3D immunocompetent in-vitro wound model for animal-free wound healing research
Poster 3.4 Basic and Translational Research
Q. Suppiyar Presenter University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery W. Ibing University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery W. Garabet University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery M. Wagenhäuser University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery H. Schelzig University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery J. Rembe University Hospital Duesseldorf , Department of Vascular and Endovascular Surgery
P118
Tapinarof restrains IL-17-producing human memory T cells through metabolic reprogramming
Poster 3.4 Basic and Translational Research
N. Bertschi Inselspital, Bern University Hospital, University of BernS. WildiF. LutherO. SteckS. SchärliR. WolfS. Radonjic-HoesliM. BenzaquenL. BorradoriC. Schlapbach Presenter
P119
Misnomers in dermatology and other medical specialties - How to deal with science fiction?
Poster 3.4 Basic and Translational Research
R. Velikova Presenter University Hospital Basel, Department of Dermatology, Basel, SwitzerlandV. Griss University Hospital Basel, Department of Dermatology, Basel, SwitzerlandP. Itin University Hospital Basel, Department of Dermatology, Basel, SwitzerlandD. Vogt Department of Clinical Research, University Hospital Basel, University of BaselS. Müller University Hospital Basel, Department of Dermatology, Basel, Switzerland
P120
IL-26+ Tissue-Resident T Cells Represent a Shared Precursor Pool for Th17 and Th2 Immunity
Poster 3.4 Basic and Translational Research
A. Burleigh Presenter CHUV & Université de LausanneJ. Botella CHUV & Université de LausanneA. Girardin CHUV & Université de LausanneJ. Di Domizio CHUV & Université de LausanneM. Gilliet CHUV & Université de Lausanne
P121
Cancer-germline antigens as potential candidates for immunotherapy in squamous cell carcinoma of the oral cavity
Poster 3.4 Basic and Translational Research
X. Berschin Presenter Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Kilic Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandD. Amozova Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Schmid Department of Pathology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Purde Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandC. Bicer Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandS. Meili Institute of Immunobiology & Department of Otorhinolaryngology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
P122
Autoreactive T-cells Targeting Melanocyte Self-Antigens in Immune Checkpoint Inhibitor-induced Vitiligo
Poster 3.4 Basic and Translational Research
C. Bicer Presenter Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandH. Glaser Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandD. Amozova Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandX. Berschin Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandR. Mendez Lopez Department of Dermatology, HOCH Kantonssiptal St. Gallen, St. Gallen, SwitzerlandM. Jörger Department of Oncology and Hematology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology, HOCH Kantonssiptal St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
P123
Cancer-Germline Antigen-Specific CD8⁺ T-cell Responses in Stage IV Melanoma Patients under Immune Checkpoint Blockade
Poster 3.4 Basic and Translational Research
D. Amozova Presenter Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandF. Berner Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Hasan Ali Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandS. Ring Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, SchwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
P124
Autocrine activation of EGFR-HER3-dependent pathways in melanoma
Poster 3.4 Basic and Translational Research
X. Berschin Presenter Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Nurmammadova Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & MD Anderson Cancer Center, UTH Huston, Houston, USAB. Broske Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Institute of Experimental Oncology, University Hospital Bonn, Bonn, GermanyH. Niessner Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyO. Pop Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
P125
Late relapse in thin melanoma: a pilot study
Poster 3.4 Basic and Translational Research
D. Amozova Presenter Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Mendez Lopez Department of Oncology and Hematology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandL. Flatz Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyR. Mendez Lopez Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, Schwitzerland
P126
Endogenous antitumor immunity is established early and persists throughout melanoma progression
Poster 3.4 Basic and Translational Research
D. Amozova Presenter Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandO. Pop Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandS. Ring Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandV. Walter Department of Dermatology, University Hospital Tübingen, Tübingen, GermanyM. Abdou Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, SwitzerlandA. Jochum Institute of Pathology, HOCH Kantonsspital St.Gallen, St.Gallen, Switzerland A. Cozzio Department of Dermatology and Allergology, HOCH Kantonsspital St.Gallen, St.Gallen, SchwitzerlandR. Dummer Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandM. Levesque Department of Dermatology, University Hospital Zurich, Zurich, SwitzerlandL. Flatz Institute of Immunobiology, HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland & Department of Dermatology, University Hospital Tübingen, Tübingen, Germany
P127
Successful Treatment of Aquagenic Pruritus with Baricitinib (Olumiant®) 4 mg
Poster 3.4 Basic and Translational Research
A. Juillerat Presenter J. GollingP. Schiller
P128
Combined dermatosurgical and CO2 ablative/fractional laser treatment of a patient with segmental Neurofibromatosis Type 1 affecting the left hemiface
Poster 3.5 Genodermatoses
N. Wyss Presenter HOCH, Kantonsspital St.GallenS. Haverkampf HOCH, Kantonsspital St.Gallen
P129
Birth-Hogg-Dubé-Syndrom: A small dermatologic detail responsible for a whole diagnosis
Poster 3.5 Genodermatoses
A. Schumacher Presenter Dermatology & Skin Care Clinic, SwitzerlandF. Ney Dermatology & Skin Care Clinic, SwitzerlandV. Emelianov Dermatology & Skin Care Clinic, SwitzerlandA. Valipour Dermatology & Skin Care Clinic, SwitzerlandA. Jalili Dermatology & Skin Care Clinic, SwitzerlandR. Genders Dermatology & Skin Care Clinic, Switzerland
P130
When itch goes genetic: A gain-of-function JAK1 variant is associated with increased JAK/STAT and IL-31 signalling
Poster 3.5 Genodermatoses
N. Bertschi Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Schärli Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandS. Wildi Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandR. Wolf Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandJ. Kick Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland L. Gogoll Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland J. Sanz Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland L. Weibel Pediatric Skin Center, Department of Dermatology, University Children's Hospital Zurich, Zurich, SwitzerlandC. Schlapbach Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandA. Reimer-Taschenbrecker Presenter Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
P131
A novel intronic LAMB3 variant c.1976+3A>T associated with an unexpectedly mild phenotype in Junctional Epidermolysis Bullosa
Poster 3.5 Genodermatoses
N. Zhovta Presenter HOCH Cantonal HospitalA. Cozzio HOCH Cantonal HospitalL. Weibel University Children's Hospital ZurichN. Knöpfel University Children's Hospital ZurichM. Theiler Pang University Children's Hospital ZurichI. Luchsinger University Children's Hospital ZurichJ. Lanz University Children's Hospital ZurichK. Steindl University of ZurichC. Has University of FreiburgA. Schwieger-Briel University Children's Hospital Zurich
P132
Fast progressive primary hypertrophic osteoarthropathy type 2 improved following etoricoxib therapy
Poster 3.5 Genodermatoses
R. Curatolo Presenter Universitätsspital Basel - DermatologieM. Madanchi Universitätsspital Basel - DermatologieA. Navarini Universitätsspital Basel - DermatologieP. Itin Praxis DermatologieV. Rusu Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland P. Chatelain Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland J. Sanz Department of Human Genetics, Inselspital, Bern Hospital, University of Bern, Bern, Switzerland P. Seitz Department of Rheumatology and Immunology, InselspitalL. Borradori Department of Dermatology Inselspital BernA. Reimer-Taschenbrecker Department of Dermatology Inselspital Bern
P133
Ablative CO2 Laser for Refractory Hailey-Hailey Disease: 30-Month Sustained Remission
Poster 3.5 Genodermatoses
N. Kechrid Presenter CHUV (Centre Hospitalier Universitaire Vaudois)M. Gilliet CHUVM. Gilliet CHUVM. Gilliet CHUVM. Gilliet CHUVF. Kuonen CHUVF. Kuonen CHUVF. Kuonen CHUVL. Tonellotto CHUVL. Tonellotto CHUVL. Tonellotto CHUVL. Tonellotto CHUV
P134
Characterization of women with x linked hypohidrotic ectodermal dysplasia
Poster 3.5 Genodermatoses
I. Luchsinger Presenter C. BodemerS. FraitagS. Hadj-Rabia
P135
Erythema nodosum as an early cutaneous sign of severe colitis in Hermansky–Pudlak syndrome type 4
Poster 3.5 Genodermatoses
I. Luchsinger Presenter M. Theiler PangL. WeibelL. WeibelN. KnöpfelN. KnöpfelJ. LanzJ. KamarachevA. Schwieger-Briel
P136
Harlequin ichthyosis: a rare genetic skin disorder and neonatal emergency requiring immediate surgical decisions
Poster 3.5 Genodermatoses
L. Weibel Presenter Universitäts Kinderspital ZürichS. Küpper University Children’s Hospital ZurichC. Gerth University Children’s Hospital ZurichI. Luchsinger Universitäts Kinderspital ZürichA. Schwieger-Briel University Children's Hospital ZurichJ. Lanz University Children's Hospital ZurichK. Neuhaus University Children’s Hospital ZurichM. Theiler Pang Universitäts-Kinderspital Zürich
P137
Treatment with Human Amniotic Membranes in a Patient with Bart Syndrome
Poster 3.5 Genodermatoses
C. Anderlini Presenter Hospital Privado Universitario de CórdobaS. Zanitti Hospital Privado Universitario de CórdobaI. Rodan Hospital Privado Universitario de CórdobaM. Salduna Hospital Privado Universitario de Córdoba
P138
Instrument-free atraumatic periosteal removal during oncologic scalp surgery
Poster 3.6 Surgery
R. Iuliano Presenter CHUV (Centre Hospitalier Universitaire Vaudois)F. Kuonen CHUV (Centre Hospitalier Universitaire Vaudois)
P139
Unexpected Admissions After Planned Outpatient Non-Melanoma Skin Cancer Reconstruction: Risk Factors and a Bedside Risk Score
Poster 3.6 Surgery
T. Schaschinger Presenter Medical Faculty, University of Heidelberg, Heidelberg, Germany F. Marcela Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt am Main, GermanyT. Niederegger Medical Faculty, University of Heidelberg, Heidelberg, Germany J. Brandt Medical Faculty, University of Heidelberg, Heidelberg, Germany D. Orgill Division of Plastic Surgery, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA A. C. Panayi Department of Cranio-Maxillofacial and Oral Surgery, University Hospital Zurich, University of Zurich, Rämistrasse 100, Zurich, 8091, SwitzerlandG. Hundeshagen Department of Hand-, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center. BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany
P140
Effective and safe surgery for keratinocyte skin cancer in the elderly over 80 years of age: a single-institution retrospective study of 345 patients over one year
Poster 3.6 Surgery
J. Hafner Presenter Dermatologische Klinik, Universitätsspital ZürichL. Fontana Dermatologische Klinik, Universitätsspital ZürichC. Richter Universitätsspital Zürich / Spital Thurgau AGR. Lang Dermatologische Klinik, Universitätsspital ZürichC. Greis Dermatologische Klinik, Universitätsspital Zürich
P141
Effectiveness of Punch Grafting in Promoting Healing and Reducing Pain in Hard-to- Heal Leg Ulcers
Poster 3.6 Surgery
J. Hafner Presenter Universitätsspital Zürich USZ und Kantonsspital BadenD. Mayer Dermatologische Klinik, Universitätsspital ZürichR. Lang Dermatologische Klinik, Universitätsspital ZürichC. Staub-BusetM. Nägeli Dermatologische Klinik, Universitätsspital ZürichJ. Hafner Dermatologische Klinik, Universitätsspital Zürich
P142
Effective and safe surgery for keratinocyte skin cancer in the elderly over 80 years of age: a single-institution retrospective study of 345 patients over one year
Poster 3.6 Surgery
J. Hafner Presenter Dermatologische Klinik, Universitätsspital ZürichL. Fontana Dermatologische Klinik, Universitätsspital Zürich und spital ZollikerbergC. Richter Dermatologische Klinik, Universitätsspital Zürich und Abteilung für Dermatologie, Spital Thurgau AGR. LangC. Greis
P143
Canvas, Oil and Paint in Dermatology. Tracing Age in Old Master Paintings
Poster 3.7 Other topics – Not defined
G. Burg Presenter University of Zurich
P144
If it itches, does it heal? Challenging the common belief that pruritus reflects wound healing
Poster 3.7 Other topics – Not defined
C. Abel-Green Presenter Department of Dermatology, University Hospital Basel, BaselM. Hofbauer Department of Dermatology, University Hospital Basel, BaselO. Brandt Department of Dermatology, University Hospital Basel, BaselS. Müller Department of Dermatology, University Hospital Basel, Basel
P145
Patient education in dermatology
Poster 3.7 Other topics – Not defined
R. Herren Presenter Inselspital BernM. Stöckli Bern University HospitalM. Giacomotti Bern University Hospital, InselspitalM. Marfurt Bern University Hospital
P146
When Nutrition Gets Under the Skin: A Modern Case of Scurvy
Poster 3.7 Other topics – Not defined
C. Richter Presenter Kantonsspital FrauenfeldS. Bender Kantonsspital FrauenfeldL. Lenherr Ramos Kantonsspital FrauenfeldA. Kistler Kantonsspital FrauenfeldS. Nobbe Kantonsspital Frauenfeld
P147
Yellow nail syndrome – always yellow?
Poster 3.7 Other topics – Not defined
S. Zürcher Presenter Inselspital - Universitätsspital BernB. SignerE. Haneke
P148
Case Report: When Horseback Riding Leaves a Mark
Poster 3.7 Other topics – Not defined
M. Hofer Presenter Kantonsspital AarauR. Dummer Kantonsspital Aarau
P149
Semaglutide-Associated Cutaneous Sensory Symptoms and Small Fiber Neuropathy: A Case Series of Five Patients
Poster 3.7 Other topics – Not defined
M. Böhm Presenter University Hospital BaselK. Berati University Hospital BaselK. Timper Technical University MunichB. Mühleisen University Hospital BaselL. Arnet Friedrich-Alexander-University Erlangen-NürnbergI. Hofer Gesundheitszentrum Fricktal AGA. Papadopoulou University Hospital BaselS. Müller University Hospital Basel
P150
Facial Discoid Dermatosis characterized by a Th17 molecular signature and clinical response to bimekizumab
Poster 1.1 Inflammatory and immune-mediated dermatoses
G. Russo Presenter Hôpitaux universitaires de Genève (HUG)S. Menzinger Hôpitaux universitaires de Genève (HUG)G. Kaya Hôpitaux universitaires de Genève (HUG)M. Gilliet CHUV DermatologieJ. Di Domizio CHUV DermatologieC. Conrad CHUV DermatologieE. Laffitte Hôpitaux universitaires de Genève (HUG)